Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Icagen updates sodium channel programs

Jan. 16, 2007

Swedish MPA approves Cipralex in OCD

Jan. 15, 2007

Rotigotine transdermal patch reduces RLS symptoms in second phase III study

Jan. 15, 2007

Phase I study of VAS-203 cleared to begin in Germany

Jan. 15, 2007

Solvay and Wyeth expand neuroscience agreement into antipsychotic research

Jan. 12, 2007

Japanese filing for mirtazapine planned for mid-2007

Jan. 12, 2007

Italian Ministry of Health requests Iplex be made available for ALS

Jan. 12, 2007

AL-108 to be studied for cognitive impairment in schizophrenia

Jan. 12, 2007

BG-12 begins phase III for relapsing-remitting MS

Jan. 12, 2007

Xytis cleared to begin phase II study of anatibant for traumatic brain injury

Jan. 12, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...